NCT06570057Recruiting
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]: Feasibility Trial in Urban Pakistan
Source: ClinicalTrials.gov · Last updated 26 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- First submitted
- 16 Aug 2024
- Start date
- 24 Jun 2024
- Primary completion date
- Nov 2026
- Lead sponsor
- Baqai Institute of Diabetology and Endocrinology
- Diseases
- Type 2 diabetes
- NCT number
- NCT06570057
What you commit to
- Study type: Interventional
- Planned participants: 240
- From 24 Jun 2024 to the primary completion date, Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with severe health conditions that may hinder their active involvement in the study.
Age
- Individuals below the age of 20 years.
Other
- Individuals unwilling to provide consent for participation.
- Individuals with non-compliance with research protocols
Who the study is looking for
- Individuals aged 20 years and above.
- Participants residing in the randomized clusters of Karachi, Pakistan
- Individuals willing to participate in the study and provide consent.
- Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
- Participants who can attend the scheduled meetings and interventions as per the study protocol.
Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baqai Institute of Diabetology and Endocrinology (BIDE) Coordinator of this site? Confirm its status | Karachi | Pakistan | Recruiting |
Related publications
- Engaging communities through participatory learning action for the control and prevention of diabetes: A protocol for the Process Evaluation of the EMPOWER-D trial in Pakistan and Afghanistan.PLoS One · 2026 · PMID 42139267
- Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of Type 2 Diabetes and its Risk factors (EMPOWER-D): protocol for a feasibility cluster randomised controlled trial in urban Pakistan.Pilot Feasibility Stud · 2026 · PMID 41630102
This page is information, not medical advice. Discuss any trial with your doctor.